ABSTRACT
INTRODUCTION
Peptides, which are often generated by cleavage from precursor proteins, are important molecules found in all organisms and play a role in a wide range of biological processes. It is this universal distribution, along with the diversity of functions that they undertake, that make peptides interesting as putative therapeutic agents, for example, as antimicrobials (Hancock and Sahl, 2006; Fjell et al., 2012) or analgesics (Diochot et al., 2012) . Peptides can function as hormones and immunomodulating agents, through interactions with cytokines, receptors and other signalling proteins (Möller et al., 2008) , and have attracted significant interest with recent appreciation of their ability to act as inhibitors or antagonists of protein-protein interaction networks (Boonen et al., 2009) . Other diverse functions include quorum sensing in the regulation of gut bacteria populations (Swift et al., 2000) ; inhibition or activation of enzymes (e.g. ACE inhibitors), membrane-bound protein channels, transporters and receptors by toxin or venom peptides (Lewis et al., 2003) ; and the disruption of cell membranes to facilitate the destruction of microbial cells by antimicrobial peptides. * To whom correspondence should be addressed While most bioactive peptides have been defined with a view to being therapeutic, not all are so, including for example toxins produced by one organism that may limit the growth of another organism, or peptides found to inhibit an enzyme in an in vitro assay. The definition of "bioactive" used here is a general catchall term for peptides having biological effects, and is representative of the concept that there may be some commonalities shared among diverse bioactive peptides derived from larger precursor proteins.
Several health benefits have been associated with bioactive peptides, particularly those derived from food sources such as plants and bovine milk (Clare and Swaisgood, 2000) . They have been shown to be functionally active, from simple dipeptides in ACE inhibition (Norris et al., 2012) , to larger milk peptides important in immunogenicity and nutrition in early development (Newburg and Walker, 2007) . Specific health promoting properties of food peptides include: antithrombotic, antimicrobial, mineral binding, opiod, immune and cytomodulatory, and blood pressure reduction, with many peptides exhibiting more than one function (Hartmann and Meisel, 2007) . Functional additives in food is an increasingly interesting area of development given the potential to deliver improvements in diet, health and resistance to infection. Peptides offer a naturally derivable source of such functional foods, and as a result there has been considerable interest in the identification of bioactive peptides in food products, particularly milk (Clare and Swaisgood, 2000) . Several peptides have already been commercialised as nutraceuticals (Korhonen and Pihlanto, 2006) demonstrating the need for more methods for the detection and characterisation of novel bioactive peptides in this area (Khaldi, 2012) .
Many databases have been created cataloguing instances of bioactive peptides. These include PepBank (Shtatland et al., 2007) , PeptideDB (Liu et al., 2008) , BIOPEP (Dziuba et al., 1999) and the antimicrobial peptide databases, APD2 (Wang et al., 2009) and CAMP (Thomas et al., 2010) . The peptide activity classes found in PeptideDB and BIOPEP include antimicrobial peptides, cytokines and growth factors, peptide hormones and toxin/venom peptides, whereas APD2 and CAMP are limited to antimicrobial peptides such as antiviral, antifungal, antibacterial and antiparasitic peptides. Such databases have facilitated the bioinformatic analysis of peptides promoting the creation of tools to aid in the identification of bioactive peptides.
The identification of bioactive peptides within protein sequences is the first step in the development of a therapeutic product. In food-based protein precursors bioactive peptides can be isolated by bacterial fermentation, or through the use of gastrointestinal or alternative proteolytic enzymes (Korhonen and Pihlanto, 2006; Vijayakumar et al., 2012) . In silico strategies used to detect novel bioactive peptides include the examination of sequence and structure homology as well as the emerging approaches of peptidomics (Sasaki et al., 2010; Khaldi, 2012) . Homology based prediction of bioactivity has successfully identified many instances of antimicrobial peptides (Lynn et al., 2004) . Other bioinformatic methods have been used to predict peptide modulators of human platelet function (Edwards et al., 2007) . As in many applications of bioinformatics, tools for the prediction of bioactivity have employed propensity scales which capture information about the statistical preferences of different amino acids to be bioactive peptides or not (Torrent et al., 2011) . Other prediction tools have been based on Support Vector Machines (SVM) (Lata et al., 2010; Thomas et al., 2010) , hidden Markov models (HMMs) (Fjell et al., 2007) or sequence alignments and feature selection (Wang et al., 2011) . Most tools focus on a particular class of bioactive peptide prediction, for example antimicrobial peptides, however, PeptideRanker , which has been developed recently, is a general bioactive peptide predictor. These tools predict the bioactivity of stand-alone peptide sequences but they are not optimised for the discovery of bioactive peptides within larger parent protein sequences, ignoring the protein context of the bioactive peptide which may provide additional information.
Here, we have combined many classes of bioactive peptides that are functionally distinct, but nevertheless have shared properties. Using the precursor protein sequences of these peptides, retrieved from PeptideDB, we have trained bidirectional recursive neural networks (BRNN), which take as input the protein sequence and a number of predicted structural features of the protein, and predict bioactive peptides within the protein sequence. As far as we are aware only one other method exists for the identification of potential bioactive peptide regions within a protein sequence and this method is specialised for the prediction of antimicrobial peptides (Torrent et al., 2012) . We have tested the performance of PeptideRanker on an independent test set of antimicrobial peptides from APD2 and followed up with an analysis of 661 food proteins from the BIOPEP database.
METHODS

Training and Test Datasets
Proteins with bioactive peptides of length less than or equal to 50 residues were retrieved from PeptideDB (Liu et al., 2008) . From 6,145 peptide precursor protein sequences we generated two internally redundancy reduced sets: PeptideDB.90 which was redundancy reduced to less than 90% sequence similarity leaving 4,505 sequences; and PeptideDB.30 which was redundancy reduced to less than 30% sequence similarity leaving 2,202 protein sequences. Fig. S1 shows the length of the bioactive peptides plotted against the length of the precursor proteins in both of these datasets.
To generate the PeptideLocator training dataset we split the PeptideDB.30 dataset into five equally sized test sets. The training set for each test set was created by running a BLAST search (Altschul et al., 1997) Table 1 . The number of protein sequences and the number of residues per class and in total for training and test datasets, and the independent test dataset.
internal redundancy reduced training sets with no BLAST hit with an evalue < 0.001 to any sequence in the corresponding test set. In summary, no sequence in a test set had > 30% sequence similarity to any other sequence in that or any other test set and no sequence was used in training a model of the network that has a BLAST hit with an e-value < 0.001 to a sequence used for testing that model. Each residue of every sequence in the datasets was labelled as either a bioactive peptide residue or non-bioactive peptide residue (Table 1) . Secondary structure, solvent accessibility, structural motifs and disorder were predicted for the full protein sequence using Porter (Pollastri and McLysaght, 2005) , PaleAle (Pollastri et al., 2007) , Porter+ (Mooney et al., 2006) and IUPred (Dosztányi et al., 2005) respectively. Each residue was labelled with the predicted probability of being in each of three classes in the case of secondary structure, four classes for solvent accessibility, fourteen classes for structural motifs and a single label representing the predicted probability of the residue being disordered. We included solvent accessibility, secondary structure and structural motifs as they provide information on the potential structure of the peptide. We included predicted disorder as this may provide information not only on the peptides structural state, but also the context of the peptide which may facilitate biological release by proteolytic cleavage or biological activity as a self-contained signalling motif unconstrained by adjacent ordered regions.
The sequences were then split into domain/non-domain sections using SMART (Letunic et al., 2009) . The input to the BRNN for each domain/nondomain protein section was the length of the section, the bioactive/nonbioactive labels per residue, the three predicted structural features (secondary structure, solvent accessibility and structural motifs), the predicted disorder per residue, and a single extra input representing if the section was, or was not, predicted to be a domain by SMART.
Independent Test Datasets
To create an independent test set we retrieved any peptide from the Antimicrobial Peptide Database (APD2) (Wang et al., 2009) which had information on the original protein sequence from which it was derived. We then searched Swiss-Prot (The UniProt Consortium, 2012) for the protein sequence. If the protein sequence was not longer than the peptide sequence it was discarded. This resulted in 132 unique protein sequences. We redundancy reduced this set to less than 30% sequence similarity to any sequences in PeptideDB.90. This left us with 15 protein sequences. Table 1 shows the number of residues per class (bioactive/non-bioactive).
Predictive Algorithms and Implementation
We use a BRNN to learn the mapping between inputs I and outputs O (protein sequence to bioactive peptide residue). BRNN have been used successfully for the prediction of secondary structure (Pollastri and McLysaght, 2005) , solvent accessibility (Pollastri et al., 2007) and structural motifs (Mooney et al., 2006) amongst other things and have the advantage over standard feed-forward neural networks that they can automatically find the optimal context on which to base a prediction, i.e. the number of residues that are informative to determine a property. Because of their recursive nature, BRNN also have a relatively low number of free parameters These networks take the form: N +1 = 0. We parametrise the output update, forward update and backward update functions (respectively N (O) , N (F ) and N (B) ) using three two-layered feed-forward neural networks.
Encoding sequence and structural information Input i j associated with the j-th residue contains primary sequence information and predicted structural information:
where, assuming that e units are devoted to sequence, and t to structural information: i
and:
Hence i j contains a total of e + t components.
We use e = 26: beside the 20 standard amino acids, B (aspartic acid or asparagine), U (selenocysteine), X (unknown), Z (glutamic acid or glutamine) and . (gap) are considered, while the 26th input encodes the length of the sequence. The frequency of gaps in a column provides information about the conservation of a site, and has proven helpful in preliminary tests. We use t = 23 for representing structural information. The first three structural input units contain the predicted three-class secondary structure representing the predicted probability of the j-th residue belonging to either helix, strand or coil. The next four input units contain the predicted probability of the j-th residue belonging to one of four solvent accessibility classes. The following 14 input units contain the predicted probability of the j-th residue belonging to one of 14 structural motifs classes, and the final two inputs are the predicted probability of the residue occurring in a disordered region or a predicted domain. Hence the total number of inputs for a given residue is e + t = 49. The output is the predicted probability of the j-th residue belonging to a bioactive peptide.
Training, Ensembling Training is conducted by five-fold crossvalidation, i.e. five sets of training are performed in which a different fifth of the overall set is reserved for testing. Before being split into the five test sets the test dataset was sorted by PeptideDB ID. We then picked instance 1 for test set 1, instance 2 for test set 2 .. etc., in an interleaved or stratified manner. As the PeptideDB IDs tend to be clustered by peptide function this ensures that all types of peptide function are distributed similarly across and present in each of the test sets.
The training set is used to learn the free parameters of the network by gradient descent. Five models are trained independently for each of the five folds i.e. 25 models in total. Differences among models in each fold are introduced by varying the architectural parameters of the network. 250 pass through the entire training set (epochs) of training are performed for each model and the learning rate (which controls how fast the algorithm converges) is halved every time we do not observe a reduction of the error for more than 50 epochs.
By the end of training 22 of the 25 models of the network have errors of less than 5%. We can therefore assume that the networks are converging to find good local optima. To test the final predictor we ensemble the five models in each of the five folds by averaging their results on their respective test sets, and then combining these five results to get the overall five-fold cross-validation result. To build the final predictor and when testing on an entirely independent set from the one used during training we ensemblecombine (average) the results across all 25 models in one step.
Evaluating Performance
To evaluate the performance of PeptideLocator we measure the true positive rate (TPR) and false positive rate (FPR) as we increase the discrimination threshold from 0 to 1. The results are shown as a Receiver Operating Characteristic (ROC) curve where TPR is plotted against FPR, which are calculated as follows:
where:
• True positives (TP): the number of residues predicted in a class that are observed in that class.
• False positives (FP): the number of residues predicted in a class that are not observed in that class.
• True negatives (TN): the number of residues predicted not to be in a class that are not observed in that class.
• False negatives (FN): the number of residues predicted not to be in a class that are observed in that class.
The area under the curve, AUC, which is equivalent to the probability that the classifier will rank a randomly chosen positive instance higher than a randomly chosen negative instance (Fawcett, 2006 ) is also shown. The AUC is a number between 0 and 1 where 0.5 indicates a random model and 1 is perfect. R is used to plot the curves and calculate the AUC (R Development Core Team, 2008) . Specificity (Spec), sensitivity (Sen), Matthews Correlation Coefficient (MCC) and the accuracy (Q) at a 0.5 threshold are measured as follows:
Q = 100 T P + T N T P + T N + F P + F N MCC measures the correlation coefficient between the observed and predicted classifications. A value of 1 represents a perfect prediction, 0 a random prediction and −1 an inverse prediction and is a good indicator of the overall performance of the predictive methods for both bioactive peptide and non-bioactive peptide residues.
RESULTS AND DISCUSSION
For every residue PeptideLocator predicts the probability between 0 and 1 of that residue being part of a bioactive peptide. The closer the probability is to 1, the more confident PeptideLocator is that the residue is part of a bioactive peptide. The results in five-fold crossvalidation for the test dataset, PeptideDB.30, are shown in Table 2 and in Fig. S2(A) as a ROC curve with thresholds from 0 to 1, i.e. the cut-off above which a residue is considered to be predicted as a bioactive peptide residue. Specificity, sensitivity and the accuracy (Q) are over well 80%, with an AUC of 92% and MCC of 0.71 showing a strong correlation between predicted and the observed classifications.
We chose secondary structure, solvent accessibility, structural motifs and disorder as additional inputs into the network as we considered these factors may contribute to the identification of a bioactive peptide within a protein sequence. We trained the networks leaving out each of these in turn and found that the results
Spec
Sen Table 2 that PeptideLocator is able to predict which class (bioactive/nonbioactive) residues fall into with an accuracy of over 82%. 90% of the bioactive peptide residues are predicted correctly. However, the FPR of 30.36% (i.e. the percentage of non-bioactive peptide residues incorrectly predicted as bioactive) is high. This could be corrected for example by increasing the threshold to 0.8 which would decrease the FPR to approximately 20% without reducing the TPR (see ROC curve Fig. S2(B) ). For this reason we have chosen a threshold of 0.8 for the food protein examples which we present below. Improved larger databases of bioactive peptides linked to precursor proteins will permit more accurate evaluation of the performance of the method we have presented, in addition to providing larger training sets for future methods development.
Peptide Activity Classes
To assess the ability of PeptideLocator to predict bioactive peptides in other classes (not only antimicrobial peptides as in APD2.30) we split the PeptideDB.30 results into six peptide activity subsets: antifreeze, antimicrobial, cytokines and growth factor, peptide hormones, toxins and venom, and unique/other. The number of residues per class are shown in Table 3 and the results are shown as ROC curves (Fig. 2) . The classes for which PeptideLocator is most accurate are antifreeze, antimicrobial and toxins and venom, which all have AUCs ≥ 95%. PeptideLocator performs worst on the cytokines and growth factor peptide activity subset, however an AUC of 86% is still high.
Predicted Bioactive Peptides in Food Proteins
To illustrate the functionality of PeptideLocator, the sequences of all proteins stored in BIOPEP were retrieved from UniProt (The UniProt Consortium, 2012). This amounted to 661 unique proteins, primarily from food, which were redundancy reduced with respect to the training set so that any protein with a BLAST alignment with more than 30% sequence similarity to any protein in the training set was removed leaving 615 protein sequences (Fig. S3) . The -bioactive  824  5665  576  43922  3367  587  Bioactive  299  7757  4825  17724  8258  6574   Total  1123  13422  5401  61646  11625  17161   Table 3 . Number of bioactive and non-bioactive residues in each of the six peptide activity classes.
sequences were submitted to PeptideLocator and the results were searched for proteins with peptide regions with y residues over a threshold x. We selected the 25 proteins which had at least 16 consecutive residues predicted over a threshold of 0.8 for further analysis (Table S1 ). None of these predicted peptide regions are found in our training set. Twelve of the proteins are less than 40 residues in length. For most of these the whole protein (or protein fragment) is labelled as bioactive (using a threshold of 0.8), and in all cases at least 80% of the residues are predicted over the 0.8 threshold. A number of these predicted peptides are alpha-amylase inhibitors from Rye (Secale cereale); alpha-amylase inhibitors are being investigated as food additives to aid in weight loss (Barrett and Udani, 2011) . The sheep lactoferrin fragment (33 residue N-terminal peptide without signal peptide) has been shown to be an inhibitor of platelet aggregation (Qian et al., 1995) . The wheat allergen peptide (ALCC WHEAT) associated with Bakers asthma (Amano et al., 1998) and wheat gluten, important in coeliac disease, were also identified.
We found that for the medium length proteins (40 -100 residues) the predicted peptide was either at the N-or C-terminus, with the exception of TIM13 ORYSJ; three of the proteins (DF39 PEA, Q9FUP3 PHACN and NO14 PEA) had signal peptides which were not predicted as bioactive. For example, PeptideLocator correctly predicted the Pisum sativum (Garden pea) bioactive peptide from Defensin-like protein 39 and has not predicted the signal peptide as bioactive (residues 1 to 28, Fig. 3 ). The experimentally validated peptide from Defensin-1 (UniProt:P81929) can be found in the CAMP database (Thomas et al., 2010) and differs from our peptide sequence only at the N-terminal lysine. It has been shown to have anti-fungal activity upon contact with a number of plant pathogen fungi (Almeida et al., 2000) . Another example is the Kunitz trypsin inhibitor protein (Q9FUP3 PHACN) from Phaseolus coccineus (Scarlet runner bean). Although not annotated as such by UniProt, there is a signal peptide predicted by SignalP (Petersen et al., 2011) at the start of this protein sequence which is not predicted as bioactive by PeptideLocator. The predicted peptide (residues 28 to 73) aligns with a peptide in the CAMP database with 54% sequence identity; this peptide is found in a Capsicum annuum secreted protein (UniProt: Q43413) and has been experimentally validated to have anti-fungal activity against Fusarium oxysporum (Thomas et al., 2010) .
Three of the longer proteins (> 100 residues) are of particular interest (Q43673 VICFA, CVCA PEA and GLCAP SOYBN). Fig.  S4 shows a strongly predicted bioactive peptide region between residues 333 and 348 in Legumin (Q43673 VICFA), a Vicia faba (Broad bean) 11S seed storage protein. Convicilin (CVCA PEA) from Pisum sativum (Garden pea) is a 7S seed storage protein. Fig.  S5 shows a strongly predicted region of bioactivity between residues 74 and 90 and another shorter peptide regions between residues 58 to 63. These proteins have also been investigated for potential ACE inhibitory activity (Vermeirssen et al., 2004) . A potential bioactive peptide of Glycine max (Soybean) Beta-conglycinin 7S seed storage protein (GLCAP SOYBN) is predicted to be in the propeptide region of the protein sequence (residues 23 -62). This protein has been shown to be a major food allergen (Krishnan et al., 2009) .
The appropriate test of these predictive methods is a large scale experimental screen that employs the prediction method developed here, ideally contrasted with a randomly selected set of peptides which ignores these predictions. Carrying out a large experiment would allow a quantification of whether the predictive power of the method is supported in the laboratory as well as in silico.
CONCLUSION
PeptideLocator can accurately identify peptide regions in protein sequences according to the likelihood that they are bioactive. We have demonstrated the use of PeptideLocator as part of a targeted identification pipeline for food peptides with beneficial properties, for example, antimicrobial peptides. It can be used in conjunction with other tools and data, for example, food hydrolysates that provide information on the proteolyic cleavage of proteins. By combining cleavage patterns with the bioactivity prediction from PeptideLocator it is possible to identify bioavailable peptides from common food, or other, proteins. Similarly, peptides predicted by PeptideLocator for a given precursor protein can act as a guide for the selection of specific enzymes that will result in their release. The utility of such an approach is demonstrated in our initial analysis of the BIOPEP dataset, showing the ability of PeptideLocator to identify peptides from a set of food proteins. There is a growing need for the identification of novel bioactive peptides in proteins and this web server is a useful addition to the repertoire of tools for investigating bioactivity.
PeptideLocator is available as part of our web server for bioactive peptide discovery and annotation. The web server implementation of the algorithm requires as input a UniProt accession number which the server uses to retrieve the sequence from UniProt (The UniProt Consortium, 2012). A graphical representation of the score per residue at a given sequence position is included in the results page, along with IUPred disorder prediction scores. The server builds an alignment of the orthologues of the protein sequence in order to provide the relative local conservation (RLC) score (Davey et al., 2009) as an additional plot in the output for metazoan sequences. The PeptideLocator score is unaffected by the presence of the RLC score for the protein; however, this is instructive in the interpretation of results. Similarly, interpretation of the likely biological context of the peptide is aided by the inclusion of disorder predictions from IUPred (Dosztányi et al., 2005) .
PeptideLocator is designed to allow fast and reliable annotation of protein sequences and is freely available for academic users at http://bioware.ucd.ie/. A packaged version of the PeptideLocator code is available by contacting the authors directly or through the Bioware Users Group (details on the PeptideLocator web page). A web service version of the software has been registered on biocatalogue.org (Bhagat et al., 2010) together with examples of how to run PeptideLocator programmatically by submitting jobs in an automated fashion.
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